MiMedx Group Inc (MDXG)
9.215
+0.16
(+1.71%)
USD |
NASDAQ |
Nov 21, 16:00
9.215
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Price to Book Value: 7.481 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 7.355 |
| November 19, 2024 | 7.501 |
| November 18, 2024 | 7.42 |
| November 15, 2024 | 7.534 |
| November 14, 2024 | 7.493 |
| November 13, 2024 | 6.064 |
| November 12, 2024 | 6.056 |
| November 11, 2024 | 6.202 |
| November 08, 2024 | 6.113 |
| November 07, 2024 | 6.04 |
| November 06, 2024 | 6.089 |
| November 05, 2024 | 5.918 |
| November 04, 2024 | 5.788 |
| November 01, 2024 | 5.626 |
| October 31, 2024 | 5.561 |
| October 30, 2024 | 4.619 |
| October 29, 2024 | 4.717 |
| October 28, 2024 | 4.757 |
| October 25, 2024 | 4.749 |
| October 24, 2024 | 4.636 |
| October 23, 2024 | 4.562 |
| October 22, 2024 | 4.644 |
| October 21, 2024 | 4.627 |
| October 18, 2024 | 4.725 |
| October 17, 2024 | 4.734 |
| Date | Value |
|---|---|
| October 16, 2024 | 4.750 |
| October 15, 2024 | 4.742 |
| October 14, 2024 | 4.652 |
| October 11, 2024 | 4.636 |
| October 10, 2024 | 4.474 |
| October 09, 2024 | 4.563 |
| October 08, 2024 | 4.547 |
| October 07, 2024 | 4.555 |
| October 04, 2024 | 4.677 |
| October 03, 2024 | 4.644 |
| October 02, 2024 | 4.709 |
| October 01, 2024 | 4.790 |
| September 30, 2024 | 4.798 |
| September 27, 2024 | 5.093 |
| September 26, 2024 | 4.936 |
| September 25, 2024 | 5.120 |
| September 24, 2024 | 5.181 |
| September 23, 2024 | 5.356 |
| September 20, 2024 | 5.356 |
| September 19, 2024 | 5.443 |
| September 18, 2024 | 5.399 |
| September 17, 2024 | 5.373 |
| September 16, 2024 | 5.434 |
| September 13, 2024 | 5.434 |
| September 12, 2024 | 5.373 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.474
Minimum
Oct 10 2024
8558.18
Maximum
Jan 03 2022
743.26
Average
20.04
Median
Jun 18 2020
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.372 |
| AIM ImmunoTech Inc | 4.627 |
| IGC Pharma Inc | 3.739 |
| NovaBay Pharmaceuticals Inc | 3.291 |
| Protalix BioTherapeutics Inc | 3.791 |
Price to Book Value Related Metrics
| PE Ratio | 15.00 |
| PS Ratio | 3.989 |
| Price to Free Cash Flow | 27.10 |
| Price | 9.215 |
| Earnings Yield | 6.67% |
| Market Cap | 1.354B |
| Operating PE Ratio | 21.48 |
| Normalized PE Ratio | 14.95 |